DE602005024590D1 - Phenothiazin-Derivat zur Wundheilung - Google Patents

Phenothiazin-Derivat zur Wundheilung

Info

Publication number
DE602005024590D1
DE602005024590D1 DE602005024590T DE602005024590T DE602005024590D1 DE 602005024590 D1 DE602005024590 D1 DE 602005024590D1 DE 602005024590 T DE602005024590 T DE 602005024590T DE 602005024590 T DE602005024590 T DE 602005024590T DE 602005024590 D1 DE602005024590 D1 DE 602005024590D1
Authority
DE
Germany
Prior art keywords
wound healing
phenothiazine derivative
skin
wound site
phenothiazinium compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005024590T
Other languages
English (en)
Inventor
Stanley Brown
Cassandra Clare O'grady
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Photopharmica Ltd
Original Assignee
Photopharmica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photopharmica Ltd filed Critical Photopharmica Ltd
Publication of DE602005024590D1 publication Critical patent/DE602005024590D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B5/00—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings
    • C09B5/24—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings the heterocyclic rings being only condensed with an anthraquinone nucleus in 1-2 or 2-3 position
    • C09B5/44—Azines of the anthracene series
    • C09B5/60—Thiazines; Oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C07D279/24—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
    • C07D279/28—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom with other substituents attached to the ring system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Surgery (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602005024590T 2004-09-20 2005-09-14 Phenothiazin-Derivat zur Wundheilung Active DE602005024590D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0420888A GB0420888D0 (en) 2004-09-20 2004-09-20 Compounds and uses
PCT/GB2005/003536 WO2006032847A1 (en) 2004-09-20 2005-09-14 Wound healing

Publications (1)

Publication Number Publication Date
DE602005024590D1 true DE602005024590D1 (de) 2010-12-16

Family

ID=33306894

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005024590T Active DE602005024590D1 (de) 2004-09-20 2005-09-14 Phenothiazin-Derivat zur Wundheilung

Country Status (11)

Country Link
US (3) US7407953B2 (de)
EP (1) EP1797053B1 (de)
JP (1) JP5118967B2 (de)
AT (1) ATE486860T1 (de)
CY (1) CY1111177T1 (de)
DE (1) DE602005024590D1 (de)
DK (1) DK1797053T3 (de)
ES (1) ES2358760T3 (de)
GB (1) GB0420888D0 (de)
PT (1) PT1797053E (de)
WO (1) WO2006032847A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113121D0 (en) 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers
CA2604399A1 (en) 2005-04-11 2006-10-19 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
BR122015013776B1 (pt) 2005-11-09 2016-12-06 Klox Technologies Inc composição, método para branqueamento de dentes e kit
US20070255356A1 (en) 2006-04-28 2007-11-01 Ondine International, Ltd. Photodisinfection delivery devices and methods
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
EP2091557A2 (de) 2006-11-15 2009-08-26 Coda Therapeutics, INC. Verbesserte verfahren und zusammensetzungen zur wundheilung
AU2008237276A1 (en) * 2007-04-03 2008-10-16 Prosetta Bioconformatics, Inc. Phenothiazin derivatives for antiviral treatments
BRPI0801368A8 (pt) * 2008-05-12 2021-03-23 Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp processos de estabilização de radicais cátion de compostos fenotiazínicos, formulações cosmecêuticas, usos de compostos fenotiazínicos na preparação de formulações cosmecêuticas e métodos de prevenção de doenças e distúrbios de pele
EP3205355A1 (de) 2008-11-07 2017-08-16 KLOX Technologies, Inc. Kombination eines oxidans und eines photoaktivators
US20100166677A1 (en) 2008-12-30 2010-07-01 Avon Products, Inc. Use of Tiliacora Triandra in Cosmetics and Compositions Thereof
AU2010265879A1 (en) * 2009-06-25 2012-02-02 Corelab Partners, Inc. Methods for assessing tophus response during urate lowering therapy in treatment tophaceous gout
KR101861547B1 (ko) 2009-06-25 2018-07-02 크레알타 파마슈티칼스 엘엘씨 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체­매개 상실을 예측하는 방법 및 키트
LT2453922T (lt) 2009-07-17 2017-12-27 Klox Technologies Inc. Antibakterinė oralinė kompozicija
JP2013515021A (ja) * 2009-12-22 2013-05-02 リスホスピタレト，コペンハーゲン ユニバーシティ ホスピタル 創傷治療製品
US8828986B2 (en) 2011-04-20 2014-09-09 Prosetta Antiviral Inc. Antiviral compounds
US8785434B2 (en) 2010-04-30 2014-07-22 Prosetta Antiviral Inc. Antiviral compounds
US9132294B2 (en) * 2010-06-30 2015-09-15 Avon Products, Inc. Compositions and methods for stimulation MAGP-1 to improve the appearance of skin
US8759336B2 (en) 2011-03-17 2014-06-24 Prosetta Antiviral Inc. Antiviral compounds
US20120301904A1 (en) 2011-04-26 2012-11-29 Prosetta Antiviral, Inc Multiprotein assemblies
US20130103123A1 (en) 2011-10-14 2013-04-25 Sazzadur Rahman Khan Light-Emitting Devices for Wound Healing
EP2833876A4 (de) * 2012-04-02 2015-09-09 Health Research Inc Zusammensetzungen und verfahren mit toll-like rezeptor (tlr)-stimulierenden wirkstoffe zur prophylaxe und therapie von schäden des dermalen epithels
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
CA2884349C (en) 2012-09-14 2019-03-26 Valeant Pharmaceuticals International, Inc. Compositions and methods for teeth whitening
CA2891291A1 (en) 2012-11-12 2014-05-15 Moontunes, Inc. Systems and methods for communicating a live event to users using the internet
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
US10272096B2 (en) 2013-06-07 2019-04-30 The Regents Of The University Of California Methods and systems of treating wounds
KR20210108505A (ko) 2013-07-03 2021-09-02 광동 클록스 바이오메디컬 그룹 씨오., 엘티디 상처를 치료하기 위한 발색단과 겔화제를 포함하는 생체광자성 조성물
US20150065943A1 (en) * 2013-08-27 2015-03-05 Matthew DeBow Method to Accelerate Healing
AR099941A1 (es) 2014-04-01 2016-08-31 Klox Tech Inc Composiciones para relleno de tejido y métodos de uso
US10153510B2 (en) 2014-06-23 2018-12-11 University Of Kentucky Research Foundation Non-aqueous redox flow batteries including 3,7-perfluoroalkylated phenothiazine derivatives
CA2958879A1 (en) 2014-08-22 2016-02-25 Auckland Uniservices Limited Channel modulators
MX2017005673A (es) 2014-10-31 2017-08-02 Klox Tech Inc Materiales de tela y fibras fotoactivables.
WO2023229659A2 (en) * 2021-10-21 2023-11-30 The General Hospital Corporation Photonic antimicrobial wound surface dressing

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE488945C (de) * 1924-09-12 1930-01-25 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von Aminoalkylaminosubstitutionsprodukten der Azin-, Oxazin- und Thiazinreihe
EP0637976B2 (de) 1992-04-30 2002-10-16 Eastman Dental Institute Medikament zur Desinfektion der Mundhöhle
DE4220736A1 (de) * 1992-06-25 1994-01-05 Puetter Medice Chem Pharm Einschlußkomplexe aus polymerisierten Cyclodextrinen mit pharmazeutisch aktiven Wirkstoffen
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
JP2001510773A (ja) * 1997-07-28 2001-08-07 ダーマトレイザー テクノロジーズ リミテッド 光線療法に基づく病原体の治療方法及びそれを達成するための組成物
AU1824300A (en) 1998-11-23 2000-06-13 Linden Biotechnology, Inc. Combination products of a guanylate cyclase inhibitor and a local anesthetic forpain relief
AU2314799A (en) * 1999-01-08 2000-07-24 David A. Browdie Tissue adhesive for treating vigorously bleeding surfaces
CN1108156C (zh) 1999-03-26 2003-05-14 夏志陶 一种主要用于手术后创口及外伤伤口的长效止痛剂
US6420455B1 (en) * 1999-06-18 2002-07-16 3M Innovative Properties Company Antimicrobial composition containing photosensitizers articles, and methods of use
US7073510B2 (en) 2000-02-11 2006-07-11 The General Hospital Corporation Photochemical tissue bonding
CA2399414A1 (en) 2000-02-11 2001-08-16 The General Hospital Corporation Photochemical tissue bonding
GB0113121D0 (en) * 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers
GB0118251D0 (en) * 2001-07-26 2001-09-19 Photocure Asa Method

Also Published As

Publication number Publication date
PT1797053E (pt) 2011-02-09
US7407953B2 (en) 2008-08-05
CY1111177T1 (el) 2015-06-11
DK1797053T3 (da) 2011-02-21
EP1797053A1 (de) 2007-06-20
GB0420888D0 (en) 2004-10-20
US20110028459A1 (en) 2011-02-03
ATE486860T1 (de) 2010-11-15
WO2006032847A1 (en) 2006-03-30
US20070161625A1 (en) 2007-07-12
JP2008513424A (ja) 2008-05-01
JP5118967B2 (ja) 2013-01-16
US20090023715A1 (en) 2009-01-22
EP1797053B1 (de) 2010-11-03
ES2358760T3 (es) 2011-05-13

Similar Documents

Publication Publication Date Title
ATE486860T1 (de) Phenothiazin-derivat zur wundheilung
CY2016031I2 (el) Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
HK1090843A1 (en) Pharmaceutical compositions for healing wounds
BRPI0408476A (pt) métodos para melhorar a qualidade da pele
DK1651161T3 (da) Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
EA200601777A1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
DK1565136T3 (da) Sammensætninger for transdermal oxybutynin-terapi
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
SE0301882D0 (sv) New use I
DK1307227T3 (da) Farmaceutiske sammensætninger
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
CY2018006I1 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
NO20071798L (no) Dermalt pafore formuleringer for behandling av hudsykdommer i dyr
UY28098A1 (es) Derivados de anilinopirazol útiles en el tratamiento de la diabetes
CY1120368T1 (el) Αλληλουχια ειδικης διασπασης μμρ-14
FR2846239B1 (fr) Composition de cosmetique destinee a blanchir la peau comprenant du senkyunolide a en tant que principe actif
AR055939A1 (es) Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso
EA200870058A1 (ru) Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран
ES2422173T3 (es) Composiciones que contienen aecuorina y procedimientos de uso de las mismas
BRPI0418764A (pt) uso de espinosina ou um derivado ou sal da mesma fisiologicamente aceitável
CY1111361T1 (el) Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια